2019
DOI: 10.1177/0284185119852731
|View full text |Cite
|
Sign up to set email alerts
|

Single-center experience with the new generation Derivo Embolization Device in ruptured dissecting and blister aneurysms

Abstract: Background Treatment of ruptured dissecting and blister aneurysms is technically challenging with potentially high morbidity and mortality. The Derivo Embolisation Device (Derivo) is a flow diverter stent designed for the treatment of intracranial aneurysms. Purpose To assess the safety and feasibility of the Derivo in the treatment of ruptured dissecting and blister aneurysms. Material and Methods We retrospectively analyzed all patients with ruptured dissecting and blister aneurysms treated with the Derivo b… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
6
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 14 publications
(7 citation statements)
references
References 30 publications
1
6
0
Order By: Relevance
“…The BBA subgroup in the review demonstrated a 35% immediate occlusion rate and an 18% overall complication rate (7). Several studies have reported 0-33.3% immediate occlusion rates and 0-27% periprocedural complication rates (25,(33)(34)(35)(36). In this study, the immediate occlusion rate and periprocedural complication rate were 16.6%, and these results are consistent with those in the literature.…”
Section: Discussionsupporting
confidence: 89%
See 1 more Smart Citation
“…The BBA subgroup in the review demonstrated a 35% immediate occlusion rate and an 18% overall complication rate (7). Several studies have reported 0-33.3% immediate occlusion rates and 0-27% periprocedural complication rates (25,(33)(34)(35)(36). In this study, the immediate occlusion rate and periprocedural complication rate were 16.6%, and these results are consistent with those in the literature.…”
Section: Discussionsupporting
confidence: 89%
“…To our knowledge, there is no article focusing on the early treatment of ruptured BBAs treated with FDs. There had been some mixed (early and delayed treatment fashion) data and only one aforementioned delayed treatment safety and efficacy report ( 3 , 8 , 25 , 30 , 33 , 35 , 38 ). Our results contribute to the safety profile of FDs in the early treatment period of ruptured BBAs of ICA with a similar outcome and complication rates compared to delayed treatment and overall data regardless of time to treatment.…”
Section: Discussionmentioning
confidence: 99%
“…So far, 12 case series of ruptured dissecting aneurysms or ruptured blood blister-like aneurysms treated in acute phase with flow diverter have been reported. [13][14][15][16][17][18][19][20][21][22][23][24] In these reports, 115 ruptured site (68 internal carotid artery, six middle cerebral artery, one anterior cerebral artery, 26 vertebral artery, six basilar artery, two posterior cerebral artery, three anterior inferior cerebellar artery, three posterior inferior cerebellar artery) were treated; 101 were treated with only flow diverter, 14 with flow diverter and coil. In these 115 cases, no rebleeding from ruptured site and 10 symptomatic thrombotic events were observed after procedure.…”
Section: Discussionmentioning
confidence: 99%
“…It has no distal or proximal device markers. The safety and efficacy of the Derivo ® device have been shown in several studies [10,[34][35][36]. Post-interventional data for Derivo ® 2 show the desired flow redirection and activity reduction inside the aneurysm, which is beneficial for thrombosis formation with marked decreases in neck flow rate and mean inflow velocity [37].…”
Section: Introductionmentioning
confidence: 92%